Clinical Trials Directory

Trials / Terminated

TerminatedNCT06841393

Assessment of Biological, Biometrological Parameters and Consumer Needs in Adult Subjects with Acne

Knowledge and Exploratory Study to Better Understand Face Acne Pathophysiology and Acne Lesion Severity by Multi-omic Approaches, Biometrological Analysis and Consumer Needs

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Pierre Fabre Dermo Cosmetique · Industry
Sex
All
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

Acne vulgaris (acne) is a chronic inflammatory pathology of the pilosebaceous unit. Its prevalence is about 85% of teenagers and is constantly increasing in adults, especially women. Acne is a multifactorial disease involving abnormalities in follicular keratinization, sebum production, skin microbiota and inflammation. The early stage of acne is characterized by the presence of primary retentional lesions: the open comedones (or blackheads) and closed comedones (or whitehead). These retentional lesions can progress to highly inflammatory lesions: superficial inflammatory lesions (papules and pustules) and in some cases in deep inflammatory lesions (nodules). Finally, acne lesions can lead to the development of superficial post inflammatory erythema or hyperpigmentation, resulting in emotional distress and a poorer quality of life. Currently, a better understanding of the switch from healthy to acne-prone skin, but also of the transition from retentional lesions to more severe inflammatory lesions, seems essential to propose adapted and specific treatments. The aim of this study is to better understand acne pathophysiology of the face by a multi-omic approaches, biometrological analysis and consumer needs collection to bring information, in the same study on the local ecosystem of non-lesional areas, retentional lesional areas and inflammatory lesional areas of adult acne prone skin, compared to acne free face.

Conditions

Interventions

TypeNameDescription
OTHERBiometrological measurementsMeasurements will be taken from the face: * For acne group: inflammatory lesional area and non-lesional area * For control group: non-lesional area
OTHERBiological samplingSamples will be taken from the face: * For acne group: inflammatory lesional area, non-lesional area and retentional area * For control group: non-lesional area
OTHERClinical assessmentsOnly for acne group: acne scores will be evaluated on the face by the investigator
OTHERQuestionnaireOnly for acne group: consumers' perception

Timeline

Start date
2023-10-16
Primary completion
2024-01-17
Completion
2024-01-17
First posted
2025-02-24
Last updated
2025-02-24

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06841393. Inclusion in this directory is not an endorsement.